We will respond quickly to the changing times in the aim of achieving further growth as a comprehensive health care company.

First, allow me to express my sincere sympathy to those who have contracted COVID-19.


The spread of this novel coronavirus has brought significant changes to our lifestyles and work styles. In the dispensing pharmacy industry, the government is considering making online diagnosis and medication guidance permanent as a regulatory reform for preventing the spread of COVID-19 and adapting to new lifestyles. Our Group will come together to respond to these changes of the times, which are taking place at a dizzying speed, with an even greater sense of urgency.


In 2020, we saw a revision of the medical service fees in the midst of COVID-19. The efforts we steadily implemented in accordance with the guidelines provided by the government have begun to bear fruit. Although the dispensing pharmacy and medical professional and placement businesses were significantly impacted by postponement of examinations to prevent the spread of COVID-19, favorable sales in the pharmaceutical manufacturing and sales business contributed greatly to the Group's earnings and continue to create synergy within the Group.


The NIHON CHOUZAI Group aims to achieve further growth as a comprehensive health care company by leveraging our collective strength.